title: Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
authors: University of Texas, Southwestern Medical Center, Dallas 75235-9063.
authors: A
authors: A
authors: Pappo
authors: R
authors: R
authors: Dubowy
authors: Y
authors: Y
authors: Ravindranath
authors: C
authors: C
authors: Alvarado
authors: S
authors: S
authors: Rao
authors: V M
authors: VM
authors: Whitehead
authors: R
authors: R
authors: Vega
authors: B
authors: B
authors: Kamen
authors: T
authors: T
authors: Vietti
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D016597:Trimetrexate
chemical_list: D011799:Quinazolines; D016597:Trimetrexate